Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2013 of 6351
-
MRI-Guided heart procedure aims to stop dangerous rhythms
Disease control CompletedPrevious monocentric experiences have already highlighted the role of preoperative cardiac imaging, in particular of cardiac magnetic resonance (CMR) and tomography (CT), in improving the ablation results of scar-related ventricular tachycardia (VT). A better characterization of …
Phase 4 • Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Stem cell treatment shows promise for knee pain relief
Symptom relief CompletedThis study aims to compare the efficacy of Umbilical Cord Mesenchymal Stem Cell and secretome between arthroscopy and without arthroscopy intervention in OA patients. This study has 4 arms namely Arthroscopy + Booster, Arthroscopy + Pre-conditioning, Non-Arthroscopy + Booster, No…
Phase 1/2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Camera pill could revolutionize bowel cancer screening
Diagnosis CompletedThe investigatior believe that implementing camera capsule endoscopy as a filter test to colonoscopy will increase screening participation, increase the number of individuals with detected intermediate- high risk adenomas or cancer, reduce the colonoscopy demand and reduce the nu…
Sponsor: Odense University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Can early weight bearing improve diabetic ankle fracture recovery?
Disease control Recruiting nowOperatively managed diabetic ankle fractures have significant risk for complications. The cause for failure is likely multifactorial, however, a component of failure has to do with an inability to process pain and pressure normally. This loss of protective sensation allows for an…
Sponsor: Kyle Schweser MD • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug cocktail aims to shrink lung tumors after standard treatment fails
Disease control Recruiting nowThe purpose of this study is to determine if the combination of the three anti-cancer drugs carboplatin, paclitaxel, and ramucirumab is helpful in shrinking tumors or delaying tumor growth in participants with non-small cell lung cancer. This study will also assess whether it is …
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can antipsychotics rewire the Brain's dopamine system? a scan study investigates
Knowledge-focused Recruiting nowThe aim of the present study is to detect changes in the dopamine system in the brain of patients with schizophrenia, especially when pretreated with antipsychotic medication. Here, the investigators want to find out whether the treatment with these drugs can cause permanent chan…
Sponsor: Central Institute of Mental Health, Mannheim • Aim: Knowledge-focused
Last updated Sep 09, 2026 22:00 UTC
-
Which ACL graft gets young athletes back in the game faster?
Disease control OngoingIn primary pediatric Anterior cruciate ligament (ACL) reconstruction, the quadriceps tendon with either tendon and patellar bone or an all-tendon graft is commonly employed. However, no randomized control trial has sought to discern the superior graft option in regards to both sh…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Pacemaker's 'Smart Pacing' may zap away heart danger without shocks
Disease control OngoingMedtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted withi…
Sponsor: Medtronic • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood test spots hidden cancer after surgery in HPV head & neck patients
Diagnosis CompletedThe purpose of this study is to test a new liquid biopsy assay for detecting residual disease after surgery in patients with HPV-associated head and neck cancer.
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Could a lower steroid dose plus exercise help boys with duchenne?
Disease control CompletedThe study team will determine the potential of low dose twice weekly prednisone and whether exercise training can synergize to delay disease progression and improve muscle strength/physical function in boys with Duchenne muscular dystrophy (DMD). Current standard of care (daily p…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New stent aims to keep leg arteries open longer
Disease control CompletedThe primary objective of this study is to confirm the safety and efficacy of the RenzanTM Peripheral Stent System when used for treatment of superficial femoral (SFA) and/or popliteal (POP) artery disease. This trial plans to include 135 patients in (up to) 10 locations around i…
Sponsor: Terumo Europe N.V. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for young cancer patients: drug shows promise against tough tumors
Disease control CompletedThe main purpose of this study is to evaluate the antitumor activity and safety of lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants were enrolled into Ewing sarcoma (EWS), rhabd…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New study tests ocrelizumab in minority MS patients
Disease control CompletedOpen-label, prospective, single-arm, multi-center study to assess disease activity and biomarker of neuronal damage in minority patients (self-identified Black or African American (AA) and Hispanic/Latino (HA) patients with relapsing multiple sclerosis (RMS) receiving treatment w…
Phase 4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug BMS-986278 tested in 403 lung fibrosis patients
Disease control CompletedThe purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants.
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stomach cancer drug combo trial halted midway
Disease control Stopped earlyA Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2 • Sponsor: Leap Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New MRI method could replace scalpel for diagnosing head artery disease
Diagnosis Recruiting nowThe research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arter…
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 26, 2026 19:14 UTC
-
Can a frailty score guide heart attack treatment for the elderly?
Knowledge-focused OngoingBackground Patients less than 80 years of age, who suffer a myocardial infarction (MI) are usually (\>90%) offered an early invasive strategy including coronary angiography possibly followed by intervention, preferably percutaneous coronary intervention (PCI). Among non ST-elevat…
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New combo for kidney cancer shows promise but trial halted early
Disease control Stopped earlyThis is a Phase III, multicenter, randomized, open-label study designed to evaluate the efficacy and safety of atezolizumab given in combination with cabozantinib versus cabozantinib alone in participants with inoperable, locally advanced, or metastatic renal cell carcinoma (RCC)…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New ACL surgery combo aims to cut Re-Tear rate in young athletes
Disease control OngoingAnterior cruciate ligament (ACL) rupture is one of the most common musculoskeletal injuries in young individuals, particularly those that are active in sports. Up to 30% of individuals under the age of 20 years suffer a re-injury to the reconstructed ACL. Revision ACLR has been a…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could fewer radiation sessions after surgery improve quality of life for head and neck cancer patients?
Disease control OngoingThere is a strong radiobiological and economic rationale for hypofractionated radiation therapy in head and neck cancer. Phase 1 of the trial aims to assess the acute toxicity and tolerability of hypofractionated radiation therapy in the post-operative setting, and to determine t…
Phase 1/2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC